Fisher Asset Management, LLC - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 253 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.

Quarter-by-quarter ownership
Fisher Asset Management, LLC ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q3 2022$10,497,000
-37.6%
500,080
-7.7%
0.01%
-33.3%
Q2 2022$16,817,000
-15.7%
541,789
+11.5%
0.01%0.0%
Q1 2022$19,946,000
-7.9%
485,787
-2.5%
0.01%0.0%
Q4 2021$21,659,000
-18.2%
498,245
-5.8%
0.01%
-25.0%
Q3 2021$26,479,000
-15.1%
528,836
+6.7%
0.02%
-20.0%
Q2 2021$31,206,000
-30.3%
495,417
+2.8%
0.02%
-37.5%
Q1 2021$44,758,000
+2.9%
481,732
-0.7%
0.03%
-3.0%
Q4 2020$43,488,000
-16.3%
485,356
-3.4%
0.03%
-26.7%
Q3 2020$51,944,000
+17.3%
502,698
-10.2%
0.04%
+4.7%
Q2 2020$44,287,000
+30.6%
560,023
-4.4%
0.04%
+2.4%
Q1 2020$33,904,000
-0.4%
585,958
-7.1%
0.04%
+23.5%
Q4 2019$34,042,000
-1.6%
630,984
-4.6%
0.03%
-10.5%
Q3 2019$34,587,000
+8.8%
661,571
+0.5%
0.04%
+8.6%
Q2 2019$31,786,000
-44.0%
657,957
-36.5%
0.04%
-2.8%
Q1 2019$56,724,000
+90.5%
1,035,725
+106.2%
0.04%
-12.2%
Q4 2018$29,769,000
+50.5%
502,181
+67.1%
0.04%
+70.8%
Q3 2018$19,780,000
+11.4%
300,475
-14.5%
0.02%
+4.3%
Q2 2018$17,751,000
-10.8%
351,575
-7.0%
0.02%
-11.5%
Q1 2018$19,894,000
-0.3%
377,863
-12.0%
0.03%0.0%
Q4 2017$19,962,000
+14.1%
429,568
-0.7%
0.03%
+4.0%
Q3 2017$17,502,000
+29.9%
432,680
+8.9%
0.02%
+25.0%
Q2 2017$13,474,000
+12.3%
397,335
-3.8%
0.02%
+5.3%
Q1 2017$11,994,000
-12.7%
413,020
-1.3%
0.02%
-20.8%
Q4 2016$13,736,000
-4.0%
418,270
-7.8%
0.02%
-4.0%
Q3 2016$14,311,000
+0.4%
453,870
-3.0%
0.02%
-3.8%
Q2 2016$14,253,000
-21.4%
467,770
+2.2%
0.03%
-23.5%
Q1 2016$18,127,000
-1.0%
457,7420.0%0.03%
-2.9%
Q4 2015$18,314,000
+40.2%
457,742
-0.2%
0.04%
+29.6%
Q3 2015$13,066,000
-14.2%
458,634
-0.8%
0.03%
-10.0%
Q2 2015$15,237,000
+5.7%
462,428
-7.8%
0.03%
+3.4%
Q1 2015$14,421,000
+5.6%
501,4280.0%0.03%
+3.6%
Q4 2014$13,654,000
+32.6%
501,428
+3.7%
0.03%
+27.3%
Q3 2014$10,300,000
-2.2%
483,328
+3.1%
0.02%0.0%
Q2 2014$10,528,000
+4.5%
468,757
+17.6%
0.02%
-4.3%
Q1 2014$10,074,000
+9.7%
398,670
-0.2%
0.02%
+9.5%
Q4 2013$9,187,000
+11.1%
399,595
-8.0%
0.02%
+5.0%
Q3 2013$8,271,000
+45.7%
434,195
+10.3%
0.02%
+33.3%
Q2 2013$5,676,000393,5950.02%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Zebra Capital Management LLC 22,111$908,0002.08%
Global Alpha Capital Management Ltd. 460,530$18,909,0001.62%
AIMZ Investment Advisors, LLC 70,625$2,900,0001.19%
Bridge City Capital, LLC 39,835$1,636,0000.76%
PALISADE CAPITAL MANAGEMENT, LP 560,409$23,010,0000.53%
EARNEST PARTNERS LLC 2,071,376$85,051,0000.50%
RICE HALL JAMES & ASSOCIATES, LLC 302,721$12,430,0000.50%
SummerHaven Investment Management, LLC 14,476$594,0000.34%
Ridgewood Investments LLC 10,004$411,0000.27%
AtonRa Partners 11,505$472,0000.26%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders